Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LEGN

Legend Biotech Corp ADR

Jul 26 • 04:00PM ET

56.61

Dollar change -2.53
Percentage change -4.28	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IBB IEMG EEMV MCHI EEM IXUS SPEM ACWV GNOM KOMP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.60	Insider Own	0.83%	Shs Outstand	181.91M	Perf Week	-3.63%
Market Cap	10.32B	Forward P/E	-	EPS next Y	-0.49	Insider Trans	0.00%	Shs Float	180.78M	Perf Month	26.11%
Income	-465.95M	PEG	-	EPS next Q	-0.29	Inst Own	47.17%	Short Float	6.12%	Perf Quarter	27.44%
Sales	342.80M	P/S	30.10	EPS this Y	23.58%	Inst Trans	19.01%	Short Ratio	9.16	Perf Half Y	-2.61%
Book/sh	6.39	P/B	8.86	EPS next Y	56.16%	ROA	-31.22%	Short Interest	11.06M	Perf Year	-24.62%
Cash/sh	7.15	P/C	7.92	EPS next 5Y	-	ROE	-51.28%	52W Range	38.60 - 77.30	Perf YTD	-5.92%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-168.48%	ROI	-31.15%	52W High	-26.77%	Beta	0.04
Dividend TTM	-	Quick Ratio	5.57	Sales past 5Y	50.60%	Gross Margin	52.35%	52W Low	46.66%	ATR (14)	2.65
Dividend Ex-Date	-	Current Ratio	5.66	EPS Y/Y TTM	20.41%	Oper. Margin	-127.12%	RSI (14)	63.96	Volatility	3.76% 5.31%
Employees	1826	Debt/Eq	0.29	Sales Y/Y TTM	231.84%	Profit Margin	-135.92%	Recom	1.25	Target Price	80.62
Option/Short	Yes / Yes	LT Debt/Eq	0.28	EPS Q/Q	51.58%	Payout	-	Rel Volume	0.81	Prev Close	59.14
Sales Surprise	-34.38%	EPS Surprise	17.31%	Sales Q/Q	158.67%	Earnings	Aug 09 BMO	Avg Volume	1.21M	Price	56.61
SMA20	9.32%	SMA50	21.37%	SMA200	1.11%	Trades		Volume	979,058	Change	-4.28%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-17-24	Initiated	Truist	Buy	$88
May-24-24	Reiterated	H.C. Wainwright	Buy	$86 → $73
May-23-24	Initiated	Deutsche Bank	Buy	$60
Apr-17-24	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$65
Apr-03-24	Initiated	Cantor Fitzgerald	Overweight	$82
Mar-13-24	Initiated	Raymond James	Outperform	$86
Dec-19-23	Initiated	Scotiabank	Sector Perform
Nov-06-23	Initiated	Goldman	Buy	$90.09
May-25-23	Initiated	William Blair	Mkt Perform	$64
May-22-23	Initiated	Daiwa Securities	Buy
Mar-29-23	Initiated	H.C. Wainwright	Buy	$66
Mar-24-23	Initiated	RBC Capital Mkts	Outperform	$73
Dec-06-22	Initiated	UBS	Buy	$66
Nov-02-22	Initiated	Evercore ISI	Outperform
Nov-01-22	Initiated	Cowen	Outperform
Oct-31-22	Initiated	Guggenheim	Neutral
Jun-17-22	Initiated	BMO Capital Markets	Outperform	$77
Mar-15-22	Initiated	Barclays	Overweight	$53
Jan-31-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$51
Jan-06-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight

Show Previous Ratings

Today 07:00AM	Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024 (GlobeNewswire)
Jul-15-24 09:17AM	Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid (Zacks)
07:39AM	Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains? (Zacks)
Jul-10-24 08:00AM	Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results (GlobeNewswire)
Jul-02-24 08:00AM	Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma (GlobeNewswire)
08:13AM	Loading…
Jun-24-24 08:13AM	Does Legend Biotech (LEGN) Have a Long Runway for Growth? (Insider Monkey)
Jun-20-24 05:26PM	Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike (PR Newswire)
Jun-03-24 04:00PM	Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA (Business Wire)
May-29-24 08:00AM	Legend Biotech to Participate in the Jefferies Global Healthcare Conference (Business Wire)
May-23-24 05:00PM	Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA (Business Wire) -7.28%
May-15-24 08:19AM	Legend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-14-24 09:23AM	HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating (MT Newswires)
06:54AM	RBC Adjusts Price Target on Legend Biotech to $86 From $85 on Model Updates, Maintains Outperform Rating (MT Newswires)
03:01AM	Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ... (GuruFocus.com)
12:20AM	Q1 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
11:53AM	Loading…
May-13-24 11:53AM	LEGN Stock Earnings: Legend Biotech Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:24AM	Sector Update: Health Care Stocks Decline Pre-Bell Monday (MT Newswires)
08:57AM	Sector Update: Health Care (MT Newswires)
07:30AM	Legend Biotech Q1 Net Loss Narrows as Revenue Rises; Shares Rise Pre-Bell (MT Newswires)
07:00AM	Legend Biotech Reports First Quarter 2024 Results and Recent Highlights (Business Wire)
May-09-24 08:52AM	Should You Buy Legend Biotech (LEGN) Ahead of Earnings? (Zacks)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-22-24 01:37PM	Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer (MT Newswires)
01:05PM	CARVYKTI (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma (Business Wire)
Apr-11-24 08:00AM	Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results (Business Wire)
Apr-08-24 08:48AM	Why Legend Biotech (LEGN) Stock Might be a Great Pick (Zacks)
Apr-05-24 11:36PM	U.S. FDA approves expanded use of J&J's cancer cell therapy (Reuters)
11:30PM	Legend Biotech's CARVYKTI (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma (Business Wire)
Apr-03-24 05:39AM	Should You Continue to Hold Legend Biotech Corporation (LEGN)? (Insider Monkey)
Mar-29-24 05:09AM	Management's Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4 (Insider Monkey)
08:30AM	Loading…
Mar-19-24 08:30AM	Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report (Business Wire)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-15-24 03:15PM	CARVYKTI (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma (Business Wire)
Mar-12-24 08:20AM	Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-11-24 07:00AM	Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights (Business Wire)
Feb-23-24 07:15AM	Legend Biotech Announces Positive CHMP Opinion for CARVYKTI (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy (Business Wire) +7.10%
Feb-13-24 08:00AM	Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-07-24 02:41AM	Matthews Emerging Markets Small Companies Fund Bolsters Position in CarTrade Tech Ltd (GuruFocus.com)
Jan-22-24 08:34PM	UPDATE 6-US FDA seeks 'boxed warning' for CAR-T cancer therapies (Reuters) +8.17%
08:11PM	US FDA requires 'boxed warning' for CAR-T cancer therapies (Reuters)
08:05AM	Should You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)? (Insider Monkey)
Jan-03-24 08:30AM	Legend Biotech Announces Closing of License Transaction for Certain CAR-T Therapies Targeting DLL3 (Business Wire)
Jan-02-24 10:29AM	Why healthcare, biotech may be top plays for 2024: BTIG (Yahoo Finance Video)
08:30AM	Legend Biotech to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-26-23 06:56PM	13 High Growth Healthcare Stocks to Buy (Insider Monkey)
Dec-19-23 11:40AM	5 Most Promising Healthcare Stocks According to Analysts (Insider Monkey)
Dec-11-23 07:30PM	Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI (ciltacabtagene autoleucel) (Business Wire)
Nov-28-23 02:51PM	FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White Blood Cells (The Wall Street Journal)
Nov-24-23 04:02PM	Legend Biotech Corporation (NASDAQ:LEGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-20-23 11:09PM	Q3 2023 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents) -6.29% -5.37%
06:00AM	Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights (Business Wire)
Nov-16-23 05:50AM	Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On (Motley Fool)
Nov-14-23 10:47AM	Should You Buy Legend Biotech (LEGN) Ahead of Earnings? (Zacks)
Nov-13-23 08:30AM	Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3 (Business Wire)
07:00AM	Novartis licenses Legend cell therapy for lung cancer (BioPharma Dive)
Nov-07-23 08:30AM	Legend Biotech to Host Investor Conference Call on Third-Quarter Results (Business Wire)
Nov-02-23 09:17AM	Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting (Business Wire)
Oct-30-23 10:39AM	Should You Expect Strong Financial Growth from Legend Biotech Corporation (LEGN)? (Insider Monkey)
Oct-20-23 05:10AM	Should You Hold Legend Biotech Corporation (LEGN)? (Insider Monkey)
Oct-03-23 05:52AM	Legend Biotech Corporation (LEGN)'s Stock Witnessed a 43% Increase in Q2 (Insider Monkey)
Sep-21-23 08:00AM	Blockbuster Cancer Treatment Stymied by Supply Chainfor Now (The Wall Street Journal)
Aug-16-23 02:40AM	Q2 2023 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-15-23 06:00AM	Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights (Business Wire)
Aug-14-23 08:36AM	Why Earnings Season Could Be Great for Legend Biotech (LEGN) (Zacks)
07:15AM	3 Biotech Stocks Poised to Beat Q2 Earnings Estimates (Zacks)
Aug-10-23 08:14AM	Top 5 Stocks Set to Beat on Earnings Next Week (Zacks)
Aug-07-23 06:57PM	3 Biotech Stocks That Analysts Are Drooling Over (InvestorPlace)
Aug-03-23 08:30AM	Legend Biotech to Host Investor Conference Call on Second-Quarter Results (Business Wire)
Aug-02-23 09:56AM	AMD upgraded, Electronic Arts downgraded: Wall Street's top analyst calls (The Fly)
Jul-25-23 02:45AM	What Makes Legend Biotech Corporation (LEGN) a Unique and Exciting Investment Opportunity? (Insider Monkey)
Jun-29-23 02:00AM	This Top-Performing Small-Cap Manager Is Betting Big on China (Barrons.com)
Jun-07-23 08:35AM	Legend (LEGN) Up 4% on sNDA Submission for Carvykti Expanded Use (Zacks)
Jun-06-23 04:30PM	Legend Biotech Announces Submission of Supplemental Application to the U.S. FDA for Expanded Use of CARVYKTI® (ciltacabtagene autoleucel) (Business Wire)
Jun-05-23 11:04AM	Ciltacabtagene Autoleucel (cilta-cel) Reduced Risk of Disease Progression or Death by 74% vs Standard Regimens for Adult Patients with Relapsed and Refractory Multiple Myeloma in CARTITUDE-4 Study (Business Wire)
Jun-02-23 04:01PM	Legend Biotech Announces Participation in Upcoming Investor Conferences (Business Wire)
May-25-23 08:30AM	Legend Biotech Announces Submission to the European Medicines Agency for Expanded Use of CARVYKTI® (ciltacabtagene autoleucel) (Business Wire)
May-23-23 03:14PM	Legend Biotech's Story Is Still Playing Out (TheStreet.com)
May-18-23 08:30AM	Legend Biotech Reports First Quarter 2023 Results and Recent Highlights (Business Wire)
May-16-23 08:35AM	Legend Biotech to Demonstrate Progress in Advancing Potential Treatment Options for Patients with Multiple Myeloma at ASCO and EHA Annual Meetings (Business Wire)
May-11-23 04:01PM	Legend Biotech Announces Participation in Upcoming Investor Conference (Business Wire)
May-08-23 08:30AM	Legend Biotech Corporation Announces Pricing of Registered Direct Offering of $350 Million of American Depositary Shares (Business Wire)
May-03-23 10:25PM	Voyager Therapeutics (VYGR) Surges 11.1%: Is This an Indication of Further Gains? (Zacks)
May-01-23 09:25AM	After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech? (Motley Fool)
Apr-21-23 04:03PM	Legend Bio Hits Profit-Taking Zone After Confirming Leaked Test Results (Investor's Business Daily) +9.33%
Apr-20-23 11:04AM	Legend (LEGN) Stock Up 20% on Data Leak From Blood Cancer Study (Zacks)
01:52AM	Legend Biotech Corporation Sponsored ADR (LEGN) Soars 19.6%: Is Further Upside Left in the Stock? (Zacks)
Apr-19-23 07:22PM	7 Biotech Stocks That Could Cure Your Portfolio Woes (InvestorPlace) +19.64%
04:06PM	Legend Breaks Out After Leaked Documents Show Promise In $9.6 Billion Market (Investor's Business Daily)
01:04PM	Legend Biotech Soars After Cancer Drug Trial Results Revealed Early (Bloomberg)
12:40PM	Why Shares of Legend Biotech Jumped Wednesday (Motley Fool)
10:22AM	Legend Biotech Breaks Out After Leaked Documents Show Big CAR-T Benefit (Investor's Business Daily)
Apr-11-23 08:30AM	Legend Biotech Announces Appointment of Chief Medical Officer (Business Wire)
Apr-03-23 04:01PM	Legend Biotech Establishes Strategic Advisory Board (Business Wire)
Apr-02-23 09:49AM	Analysts Are Upgrading Legend Biotech Corporation (NASDAQ:LEGN) After Its Latest Results (Simply Wall St.)
Apr-01-23 09:45AM	Legend Biotech's (NASDAQ:LEGN) growing losses don't faze investors as the stock rises 4.7% this past week (Simply Wall St.)
09:00AM	Legend Biotech Full Year 2022 Earnings: Revenues Miss Expectations (Simply Wall St.)
Mar-30-23 04:01PM	Legend Biotech Reports Full-Year 2022 Results and Recent Highlights (Business Wire)
Mar-29-23 08:54PM	7 Biotech Stocks to Buy for Breakthrough Treatments and Cures (InvestorPlace)
04:40PM	12 Most Promising Healthcare Stocks According to Analysts (Insider Monkey)
Mar-24-23 02:47AM	Should You Retain Your Holdings in Legend Biotech Corporation (LEGN)? (Insider Monkey) +5.11%

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LEGN

Legend Biotech Corp ADR

Upgrade your FINVIZ experience